Perimeter Medical Imaging AI, Inc. (PINK.V)
CAD 0.43
(6.25%)
CAD 0.43
(6.25%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.09 Million CAD | -16.43% |
| 2022 | 8.49 Million USD | 231.52% |
| 2021 | 2.56 Million CAD | 6.81% |
| 2020 | 2.39 Million CAD | -87.4% |
| 2019 | 19.02 Million CAD | 7390.95% |
| 2018 | 253.97 Thousand CAD | -6.14% |
| 2017 | 270.59 Thousand CAD | 17.82% |
| 2016 | 229.66 Thousand CAD | 50.54% |
| 2015 | 152.56 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.5 Million USD | -35.95% |
| 2024 Q2 | 3.02 Million USD | -13.73% |
| 2023 Q4 | 5.47 Million USD | 1.74% |
| 2023 Q1 | 7.36 Million USD | -13.26% |
| 2023 Q3 | 5.38 Million USD | -36.97% |
| 2023 FY | 7.09 Million CAD | -16.43% |
| 2023 Q2 | 8.54 Million USD | 15.96% |
| 2022 Q2 | 11.96 Million CAD | -24.76% |
| 2022 FY | 8.49 Million USD | 231.52% |
| 2022 Q1 | 15.9 Million CAD | 520.9% |
| 2022 Q3 | 11.24 Million CAD | -6.0% |
| 2022 Q4 | 8.49 Million USD | -24.51% |
| 2021 Q1 | 2.04 Million CAD | -14.67% |
| 2021 FY | 2.56 Million CAD | 6.81% |
| 2021 Q4 | 2.56 Million CAD | 3.5% |
| 2021 Q3 | 2.47 Million CAD | -27.37% |
| 2021 Q2 | 3.4 Million CAD | 66.52% |
| 2020 Q2 | 6.51 Million CAD | -70.26% |
| 2020 FY | 2.39 Million CAD | -87.4% |
| 2020 Q4 | 2.39 Million CAD | -10.33% |
| 2020 Q3 | 2.67 Million CAD | -58.95% |
| 2020 Q1 | 21.9 Million CAD | 15.12% |
| 2019 FY | 19.02 Million CAD | 7390.95% |
| 2019 Q4 | 19.02 Million CAD | 0.0% |
| 2018 FY | 253.97 Thousand CAD | -6.14% |
| 2017 FY | 270.59 Thousand CAD | 17.82% |
| 2016 FY | 229.66 Thousand CAD | 50.54% |
| 2015 FY | 152.56 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Therma Bright Inc. | 2.16 Million CAD | -227.759% |
| Theralase Technologies Inc. | 1.37 Million CAD | -417.379% |
| VentriPoint Diagnostics Ltd. | 1.69 Million CAD | -318.92% |